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The Saccharomyces cerevisiae SCS7 and SUR2 genes
are members of a gene family that encodes enzymes that
desaturate or hydroxylate lipids. Sur2p is required for
the hydroxylation of C-4 of the sphingoid moiety of ceramide, and Scs7p is required for the hydroxylation of
the very long chain fatty acid. Neither SCS7 nor SUR2
are essential for growth, and lack of the Scs7p- or Sur2pdependent hydroxylation does not prevent the synthesis
of mannosyldiinositolphosphorylceramide, the mature
sphingolipid found in yeast. Deletion of either gene suppresses the Ca21-sensitive phenotype of csg2D mutants,
which arises from overaccumulation of inositolphosphorylceramide due to a defect in sphingolipid mannosylation. Characterization of scs7 and sur2 mutants is
expected to provide insight into the function of ceramide hydroxylation.

Sphingolipids, essential components of eukaryotic plasma
membranes, consist of a hydrophilic head attached to a ceramide. Ceramides contain a fatty acid attached to a sphingoid base
through an amide linkage (Fig. 1). They can be classified according to their level of hydroxylation (1); both the sphingoid
and the fatty acid moieties are found with different levels of
hydroxylation (Fig. 1). In mammals, the sphingoid moiety is
mostly sphingosine, which is desaturated at C-4,5; however,
some is phytosphingosine that is hydroxylated at C-4, or dihydrosphingosine, which is neither desaturated at C-4,5 nor hydroxylated at C-4 (2, 3). In the yeast Saccharomyces cerevisiae,
the C-4 is mostly hydroxylated (1). The fatty acid that is attached to the sphingoid base is either un-, mono-, or dihydroxylated (1). In yeast, the first hydroxylation of the fatty acid
moiety occurs in the endoplasmic reticulum, and the second
hydroxylation is in the Golgi apparatus (4) and requires Cu21
and the Golgi copper transporter encoded by CCC2 (5).
The physiological role of the different hydroxylation states is
not known. Hydroxylation of ceramide and sphingolipids may
alter their cellular location, their effect on the physical properties of membranes, and their interaction with proteins either
as a substrate or regulator. Identification of the genes and
proteins required for the hydroxylation reactions will facilitate
the investigation of the function of the hydroxyl groups.
The S. cerevisiae protein Scs7p is required for the first hydroxylation of the ceramide fatty acid moiety (6). This enzyme
belongs to a family of desaturase/hydroxylase enzymes that
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contain an oxo-diiron domain (Fe-O-Fe) (7, 8). This domain
consists of four transmembrane segments. The loop between
the second and third transmembrane segments has a histidinecontaining motif (HX3,4HX8 –31HX2,3HH). Another histidinerich motif (HX2,3HH or HX2,3HX13–39HX2,3HH) follows the
fourth transmembrane segment. Sur2p also contains the oxodiiron motif (9).
The SUR2 gene was initially identified in a screen for suppressors of rvs161 mutants (10). Rvs161p is required for endocytosis (11), correct actin localization (12), and viability upon
nitrogen, carbon, or sulfur starvation (13). It is similar to
amphiphysin, a neuronal protein found in synaptic vesicles
that is the autoantigen in stiff-man syndrome (14, 15). The
molecular function of Rvs161p and the basis of suppression by
mutations in the SUR genes have not been identified. However,
other SUR genes have been found to function in sphingolipid
synthesis. SUR1 is allelic to CSG1, a gene required for mannosylation of sphingolipids (5). SUR4/ELO3 encodes a fatty
acid elongase required for the synthesis of the very long chain
fatty acids (VLCFA)1 found in ceramide and sphingolipid (16).
The genetic relationship between SUR2, SUR1, and SUR4
suggests that SUR2 may also be involved in sphingolipid
synthesis.
Based on the homology of Sur2p with Scs7p, required for
hydroxylation of the fatty acid of sphingolipids (6), and the
genetic relationship between SUR2 and other sphingolipid synthesis genes, the possibility that SUR2 is required for hydroxylation of C-4 on the long chain base (LCB) found in sphingolipids was investigated.
EXPERIMENTAL PROCEDURES

Yeast Strains and Media—The yeast strains used in this study were
TDY2037 (Mata lys2 ura3-52 trp1D leu2D), TDY2038 (Mata lys2
ura3-52 trp1D leu2D csg2::LEU2), 2037scs7D (Mata lys2 ura3-52 trp1D
leu2D scs7::LEU2), and 6715b (Mata lys2 ura3-52 trp1D leu2D
csg2::LEU2 scs7::LEU2). SUR2 was disrupted in these strains as described below. Media were prepared, and cells were grown using standard procedures (17). Phytosphingosine, dihydrosphingosine, and sphingosine were purchased from Sigma and added to the growth medium at
25 mM in 1% Tergitol.
Constructing the sur2 Null Mutant—In an unrelated study we isolated a YCp50-based plasmid containing a fragment of yeast DNA that
included the amino terminus (through to a Sau3A site at codon 120) of
the SUR2 gene. A restriction fragment extending from the HindIII site
367 base pairs upstream of the start codon of the SUR2 gene to the SaII
site in YCp50 was subcloned from this plasmid into pUC19. The resulting plasmid was linearized at the PstI site in codon 9 of the SUR2 gene,

1
The abbreviations used are: VLCFA, very long chain fatty acid; LCB,
long chain base; FAME, fatty acid methyl ester; HVLCFA, hydroxylated
very long chain fatty acid; NVLCFA, unhydroxylated very long chain
fatty acid; HVLCFAME, hydroxylated very long chain fatty acid methyl
ester; NVLCFAME, unhydroxylated very long chain fatty acid methyl
ester; AcOH, acetic acid; MeOH, methanol; BuOH, butanol; (Et)2O,
diethyl ether; IPC, inositolphosphorylceramide; MIPC, mannosylinositolphosphorylceramide; M(IP) 2 C, mannosyldiinositolphosphorylceramide.
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FIG. 1. The mannosylinositolphosphorylceramide (MIPC) biosynthetic
pathway and the structure of ceramide. Hydroxyl groups on C-1 and C-3 are
found on all LCBs. Sites labeled I through
III are potentially hydroxylated. Site I is
on C-4 of the LCB, site II is on C-2 of the
VLCFA, and site III is also on the VLCFA,
but the position has not been determined.
Five species (A, B, B9, C, and D) of ceramides, IPCs, or MIPCs, which differ according to which of the three sites are hydroxylated, are synthesized. In this
report, it is shown that hydroxylation of
site I and site II requires Sur2p and
Scs7p, respectively. Ceramide is converted to IPC by IPC synthase (reaction
1), and IPC is converted to MIPC by mannosylation (reaction 2).

treated with Bal-31 to remove about 100 base pairs, and incubated with
dNTPs, Klenow fragment, ligase, and XhoI linkers. A candidate plasmid with a XhoI linker at the deletion junction that was missing about
50 base pairs from each side of the original PstI site was used to
construct the disrupting plasmid. A SalI fragment carrying the TRP1
gene was ligated into the XhoI site, the SUR2-disrupting fragment was
cut out of the pUC19 plasmid with PvuII and used in a one-step gene
replacement (18). The disruption of SUR2 was confirmed using a polymerase chain reaction.
Sphingolipid Analysis—Cells were grown in synthetic minimal medium containing 12 nM inositol and 1 mCi/ml [3H]myoinositol for several
generations (from A600 0.01 to A600 1.0). Cells (about 5 A600 units) were
pelleted and washed with 4 mM sodium azide. Lipids were extracted
into 600 ml of CHCl3:MeOH (1:1) by vortexing with glass beads, removing the CHCl3:MeOH to a fresh tube and washing the cell pellet and
beads with 600 ml of CHCl3:MeOH:H2O (10:10:3). The pooled extract
was dried, alkali-treated, and BuOH-desalted as described previously
(5, 19, 20). The samples were analyzed by TLC on silica gel plates using
CHCl3:MeOH:AcOH:H2O (16:6:4:1.6) as the developing solvent (4).
Ceramide Isolation and Analysis—Cells were grown in synthetic
medium at 26 °C, spun down, and washed once with H2O. The cells
were vortexed with glass beads in hexane:EtOH (95:5) at 40 A600/ml.

The supernatant was transferred to a fresh tube, the pellet and beads
were washed with hexane:EtOH, and the pooled extract was dried. The
lipids from 60 A600 units of cells were alkali-treated by suspending in 1
ml of EtOH:H2O:Et2O:pyridine (15:15:5:1) and adding KOH to 0.1 M
followed by incubation at 37 °C for 3 h (21). After neutralizing with 1 M
AcOH, the sample was dried, BuOH-desalted (20), and dried again.
Ceramides were analyzed by TLC on silica gel plates using CHCl3:
MeOH:AcOH (95:4.5:0.5) as the developing solvent (22). Plates were
sprayed with 10% copper sulfate in 8% orthophosphoric acid and heated
for 20 min at 180 °C to char the ceramides (22). The arsenite and borate
treated silica gel plates were supplied by Analtech (Newark, DE).
Isolation of Ceramides by Preparative Silica Gel TLC—Ceramides
were purified and separated by TLC as described above. The ceramides
were visualized by ultraviolet light after spraying the plates with 0.01%
8-anilino-1-napthalenesulfonic acid. The silica gel was scraped off the
plate, and the ceramides were eluted by repeated sonication (five times
for 10 min each) in 2 ml of CHCl3:MeOH (1:1).
Isolation of Sphingolipids by Preparative Silica Gel TLC—Sphingolipids were extracted from 600 A600 units of cells by vortexing with glass
beads in 100 ml of CHCl3:MeOH (1:1). The extract was dried, alkalitreated, and BuOH-desalted as described previously (5, 19, 20). The
sample was spotted in a line on a silica gel plate and developed using
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CHCl3:MeOH:AcOH (95:4.5:0.5). In this system, fatty acids and ceramides migrate while sphingolipids remain at the origin. The material left
at the origin was subjected to acid methanolysis for analysis of the fatty
acid methyl esters (FAMEs) and LCBs as described below.
Acid Methanolysis of Ceramides and Sphingolipids and Isolation of
FAMEs and LCBs—Ceramides and sphingolipids were purified by silica gel TLC as described above. The purified ceramides or sphingolipids
were subjected to acid methanolysis by resuspending in 2 ml of HCl:
MeOH:H2O (3:29:4) and incubating at 78 °C for 18 h (23). The FAMEs
were recovered by extracting 3 times with 2 ml of hexane (24). The
extracts were pooled, dried, and subjected to TLC using petroleum
ether:Et2O (17:3) as the developing solvent (24). Plates were sprayed
with 10% copper sulfate in 8% orthophosphoric acid and heated for 20
min at 180 °C to char the FAMEs.
The LCBs were recovered from the hydrolyzed ceramides or sphingolipids by adjusting the pH of the acid hydrolysate (after extraction of

FIG. 2. Analysis of sphingolipids from wild-type (lane 1), csg2D
(lane 2), sur2D (lane 3), scs7D (lane 4), sur2Dscs7D (lane 5)
csg2Dsur2D (lane 6), csg2Dscs7D (lane 7), and csg2Dsur2Dscs7D
(lane 8) cells. Cells were labeled with [3H]inositol, and sphingolipids
were extracted and separated by silica gel TLC as described under
“Experimental Procedures.” The sphingolipids were visualized by autoradiography. The strains, designated only by the relevant gene disruptions, are derivatives of TDY2037. The hydroxylation states of the
sphingolipid species, denoted as IPC-A, IPC-B, IPC-B9, and IPC-C or
MIPC-A, MIPC-B, MIPC-B9, and MIPC-C, are presented in Fig. 1.

FAMEs) to 11.5 using 1 M NaOH and extracting three times with 2 ml
of Et2O (24). The pooled extracts were dried, and the LCBs were
separated by silica gel TLC using CHCl3, MeOH, 2.5 M NH4OH (40:10:1)
as developing solvent (24). Plates were sprayed with 0.2% ninhydrin in
ethanol and incubated at 100 °C for 5–10 min to visualize the aminecontaining LCBs.
RESULTS

Sphingolipid Synthesis Is Altered in sur2D Mutant Cells—
The main purpose of this study was to determine if SUR2
encodes the enzyme that hydroxylates C-4 of the sphingoid
moiety of sphingolipids. The sur2D mutant was constructed as
described under “Experimental Procedures.” Sphingolipid synthesis in a sur2D mutant was compared with that of wild-type.
Cells were grown for several generations in synthetic minimal
medium containing 12 nM inositol with 1 mCi/ml [3H]inositol.
[3H]Inositol was incorporated into phosphatidylinositol, inositolphosphorylceramide (IPC), mannosylinositolphosphorylceramide (MIPC) and mannosyldiinositolphosphorylceramide
(M(IP)2C). These lipids were extracted out of the cell, alkalitreated to remove phosphatidylinositol, and separated by TLC
(Fig. 2). The sphingolipid composition of the sur2D mutant cells
differs from that of wild-type cells (Fig. 2, lane 1 and 3). The
predominant sphingolipid in wild-type cells is MIPC-C (lane 1,
MC) along with its precursor IPC-C (C). IPC-D (D) containing
dihydroxyl fatty acid is also observed (1). The major sphingolipids in sur2D mutants (lane 3) differ from those of wild-type
cells. These sphingolipids are named MIPC-A and MIPC-B9
(lane 3, MA and MB9) for reasons discussed below.
Sphingolipid synthesis in a sur2Dcsg2D double mutant (lane
6) was compared with that in a csg2D mutant (lane 2). The
csg2D mutants are defective in mannosylation of inositolphosphorylceramide (17), therefore the sphingolipids in a csg2D
mutant are IPC-C and IPC-D (lane 2, C and D). The
sur2Dcsg2D double mutant accumulates two sphingolipid species IPC-A and IPC-B9 (lane 6, A and B9) that are not found in
wild-type cells. IPC-A and IPC-B9 are more hydrophobic than is
IPC-C (lane 6). The two sphingolipids found in a sur2D single
mutant, MIPC-A and MIPC-B9, (lane 3, MA and MB9) are the
mannosylated forms of the sphingolipid species seen in a
sur2Dcsg2D double mutant, IPC-A and IPC-B9 (lane 6, A and B).
The LCB species present in the inositolphosphorylceramides

FIG. 3. Analysis of the LCB moiety (panel A) and the VLCFA (panel B) of sphingolipids extracted from wild-type (lane 1), csg2D
(lane 2), csg2Dsur2D (lane 3), csg2Dscs7D (lane 4), and csg2Dsur2Dscs7D (lane 5) mutants. Sphingolipids were purified by TLC as described
under “Experimental Procedures.” The sphingolipids were subjected to acid methanolysis, and the liberated FAMEs were extracted with hexane
and separated by silica gel TLC (panel B). Plates were sprayed with 10% copper sulfate in 8% orthophosphoric acid and heated for 20 min at 180 °C
to char the FAMEs. Ten mg of hydroxylated C18 and C24 FAMEs (lanes 5 and 6) and nonhydroxylated C18 and C24 FAMEs (lanes 7 and 8)
standards (Sigma) were spotted. The position of the NVLCFAME and HVLCFAME are labeled in the right margin. The spots that migrate just
below the NVLCFAMEs as well as those migrating below the HVLCFAMEs are artifacts generated (even in the absence of added lipid) from the
acid methanolysis. After extraction of the FAMEs, the pH of the remaining solution was adjusted to 11.5 with NaOH, and the LCBs were extracted
with Et2O and analyzed by TLC (panel A). The LCBs were visualized by spraying with 0.2% ninhydrin in ethanol and heating at 100 °C for 5–10
min. Ten mg of phytosphingosine (PS), dihydrosphingosine (DS), and sphingosine (S) standards (Sigma) were spotted.
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FIG. 4. Exogenous phytosphingosine restores synthesis of
IPC-C to the csg2Dsur2D double mutant. Wild-type (lanes 1–3),
csg2D (lanes 4 – 6), csg2Dsur2D (lanes 7–9), or csg2Dscs7D (lanes 10 –12)
mutant cells were grown for several generations in synthetic medium
containing 12 nM [3H]inositol at 1 mCi/ml. Where indicated, 25 mM
phytosphingosine (PS) or dihydrosphingosine (DS) was included in the
growth medium, which contained 1% Tergitol. Sphingolipids were analyzed as described in Fig. 2.

from sur2Dcsg2D mutants (IPC-A and IPC-B9) was determined.
Polar lipids were extracted and alkali-treated to hydrolyze the
glycerol-based phospholipids, and the sphingolipids were isolated by preparative TLC as described under “Experimental
Procedures.” The sphingolipids were subjected to acid methanolysis to hydrolyze both the phosphodiester bond between the
inositol and the ceramide, and the amide bond between the
sphingoid moiety and the VLCFA. The LCB was extracted and
analyzed by TLC (Fig. 3A). The LCB in the sphingolipids from
the sur2D mutant cells (lanes 3 and 5) is exclusively dihydrosphingosine, while the sphingolipids from cells with a wildtype SUR2 gene (lanes 1, 2, and 4) contain primarily
phytosphingosine.
The FAMEs released by methanolysis were also analyzed
using a TLC system which resolves unhydroxylated very long
chain fatty acid methyl esters (NVLCFAME) and hydroxylated
very long chain fatty acid methyl esters (HVLCFAME). The
sphingolipids from sur2Dcsg2D mutant cells (lane 3) contain
both hydroxylated and unhydroxylated fatty acids (Fig. 3B).
Because sur2Dcsg2D mutant cells synthesize two sphingolipids,
IPC-A and IPC-B9, these results indicate that IPC-A contains
unhydroxylated fatty acids, whereas IPC-B9 contains hydroxylated fatty acids.
The hydroxylation of the VLCFA is dependent on Scs7p (Fig.
3B). Cells lacking both Scs7p and Csg2p synthesize an IPC-B
species (Fig. 2, lane 7) (6, 19), which contains mostly phytosphingosine as the LCB (Fig. 3A, lane 4) and an unhydroxylated VLCFAME (Fig. 3B, lane 4). Like IPC-B9, IPC-B can be
mannosylated if Csg2p is present (Fig. 2, lane 4, MB) (6, 19).
In a sur2Dscs7Dcsg2D triple mutant where hydroxylation of
C-4 of the LCB is blocked by deletion of SUR2, hydroxylation of
the VLCFA is blocked by deletion of SCS7, and mannosylation
is blocked by deletion of CSG2, the only sphingolipid synthesized is the very hydrophobic IPC-A (Fig. 2, lane 8, A). The
IPC-A species can be mannosylated if Csg2p is present (Fig. 2,
lane 5, MA). The sur2D mutants accumulate some IPC-A or
MIPC-A even when Scs7p is present (Fig. 2, lanes 3 and 6, MA
and A) suggesting that phytosphingosine-containing substrates are preferred by Scs7p over dihydrosphingosine-containing substrates. These data (summarized in the model
shown in Fig. 1) support the proposal that Sur2p is the hydroxylase that converts dihydroceramide to phytoceramide.
The Sphingolipid Synthesis Defect Conferred by Deletion of
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FIG. 5. Analysis of ceramides from wild-type, csg2D,
csg2Dsur2D, csg2Dscs7D, and csg2Dsur2Dscs7D cells. Nonpolar lipids were extracted from 10 A600 units of wild-type (lane 3), csg2D (lane
4), csg2Dsur2D (lane 5), csg2Dscs7D (lane 6), or csg2Dsur2Dscs7D (lane
7) mutant cells, alkali-treated, BuOH-desalted, and separated by TLC
as described under “Experimental Procedures.” Four mg of bovine type
III (sphingosine and unhydroxylated fatty acid, lane 1) and type IV
(sphingosine and hydroxylated fatty acid, lane 2) ceramide standards
(Sigma) were spotted. Ceramides from 100 A600 units of cells were
purified by preparative TLC, and 6% were analyzed (lanes 8 –12). The
hydroxylation states of the ceramide species are shown in Fig. 1.

sur2 Is Corrected by Exogenous Phytosphingosine but Not Dihydrosphingosine—S. cerevisiae cells can incorporate exogenous phytosphingosine into sphingolipids (25). As would be
predicted if Sur2p is required for hydroxylation of C-4 on the
LCB, exogenous phytosphingosine, but not dihydrosphingosine, restores synthesis of IPC-C to a sur2Dcsg2D mutant
(Fig. 4, lanes 8 and 9). A sur2Dscs7Dcsg2D triple mutant, that
normally makes IPC-A, makes IPC-B in the presence of phytosphingosine (data not shown). These observations provide further evidence that the altered sphingolipids that accumulate in
the sur2Dcsg2D and sur2Dcsg2Dscs7D mutants (IPC-B9 and
IPC-A, respectively) differ from the sphingolipids in csg2D and
csg2Dscs7D mutants (IPC-C and IPC-B, respectively) in the
LCB. Addition of phytosphingosine to the scs7Dcsg2D mutant
does not result in any IPC-C synthesis (Fig. 4, lane 11), because
the IPC-B that accumulates in the scs7D mutant arises from
failure to hydroxylate the VLCFA (6).
Deleting the SUR2 or SCS7 Gene Reduces Hydroxylation of
Ceramides—The IPCs are synthesized by the transfer of phosphoinositol from phosphatidylinositol to ceramide. Comparison
of ceramides isolated from the sur2Dcsg2D, scs7Dcsg2D and the
sur2Dscs7Dcsg2D mutants with ceramides from wild-type or
csg2D mutant cells demonstrates that the altered mobility of
the sphingolipids arises from differences in the ceramide moiety of the sphingolipids. Yeast ceramides were analyzed by
TLC (Fig. 5). The predominant ceramide in wild-type and in
csg2D mutant cells (lanes 3 and 4), labeled “C” (for C-ceramide)
because it is the ceramide of IPC-C, migrates slower in this
TLC system than the bovine hydroxylated ceramide standard
(Sigma type IV, lane 2) which consists of sphingosine and a
hydroxylated fatty acid. Analysis of the LCB and VLCFA of the
C-ceramide by TLC following methanolysis confirms that it
contains phytosphingosine (Fig. 6A, lanes 5 and 6) and a HVLCFA (Fig. 6B, lanes 6 and 7) (1, 26). The slower mobility of
yeast ceramide compared with hydroxylated bovine ceramides

29708

Ceramide Hydroxylation by Scs7p and Sur2p

FIG. 6. The LCBs and the FAMEs from A-, B*-, B-, and C-ceramides were analyzed by silica gel TLC. Ceramides purified from 100
A600 units of cells (see Fig. 5) were subjected to acid methanolysis, and
FAMEs and LCBs were extracted for analysis as described in Fig. 3. A,
the LCBs were separated by silica gel TLC. Standards were the LCB
derived from acid methanolysis of 4 mg of Sigma type III bovine ceramide (lane 1) and 10 mg of sphingosine (S), dihydrosphingosine (DS), and
phytosphingosine (PS). The LCBs were visualized by spraying with
0.2% ninhydrin in ethanol and heating at 100 °C for 5–10 min. B, the
FAMEs were also separated by TLC. Standards were the FAMEs derived from acid methanolysis of Sigma type III and type IV bovine
ceramides (4 mg) (lanes 1 and 2), and 10 mg of C18 FAME, C24 FAME,
and hydroxylated C24 FAME (lanes 3–5). The plate was sprayed with
10% copper sulfate in 8% orthophosphoric acid and heated for 20 min at
180 °C to char the FAMEs.

is expected, since it contains an additional hydroxyl group
(phytosphingosine versus sphingosine).
The major ceramide from sur2D mutant cells (B9-ceramide)
has a mobility similar to the hydroxylated bovine ceramide
standard. Ceramides having dihydrosphingosine might be expected to have similar hydrophobicity to those having sphingosine. The LCB from the B9-ceramide is dihydrosphingosine
(Fig. 6A, lane 7) and the VLCFA is hydroxylated (Fig. 6B,
lane 8).
The B-ceramide that accumulates in the scs7D mutant cells
contains phytosphingosine (Fig. 6A, lane 8) and unhydroxylated VLCFA (Fig. 6B, lane 9). The mobility of the ceramide in
scs7D mutant cells is quite distinct from that in sur2D mutant
cells (Fig. 5, lanes 5 and 6). Either hydroxylation of the VLCFA
increases the hydrophilicity of the ceramide less than does the

hydroxylation of the LCB, or these species interact differently
with the silica gel matrix.
The A-ceramide that is present in the sur2Dscs7D double
mutant (Fig. 5, lane 7) migrates with the unhydroxylated bovine ceramide standards as would be expected if it lacks hydroxyl groups on both C4 of the LCB and on the VLCFA (Fig. 5,
lanes 1 and 7). The LCB of the A-ceramide is dihydrosphingosine (Fig. 6A, lane 9) and the VLCFA is unhydroxylated (Fig.
6B, lane 10). The absence of vicinal hydroxyl groups (C-3 and
C-4 of phytosphingosine) on ceramide from sur2D mutants is
also indicated by the effect of the glycol-complexing ions arsenite and borate on the chromatographic behavior of the B9- and
A-ceramides (Fig. 7). The complex between vicinal hydroxyl
groups with arsenite increases their mobility on silica gel,
while the borate complex decreases their mobility (27, 28). The
mobility of C-ceramide (from wild-type and csg2D mutant cells)
and B-ceramide (from csg2Dscs7D mutant cells) is greatly increased by addition of NaAsO2 to the silica gel (compare Fig. 7,
B to A, lanes 1, 2, and 4) and reduced by addition of Na2B4O7
(Fig. 7C, lanes 1, 2, and 4), indicating that these ceramides
contain the C-3,4 vicinal hydroxyl groups of phytoceramide.
The mobility of the B9-ceramide (from csg2Dsur2D mutant
cells) and A-ceramide (from csg2Dsur2Dscs7D mutant cells) is
much less affected by arsenite or borate, consistent with the
conclusion that they have dihydrosphingosine instead of phytosphingosine as the LCB.
Deletion of the SUR2 Gene Suppresses Ca21 Sensitivity of
csg2 Mutants—Cells lacking the CSG2 gene are defective in
mannosylation of inositolphosphorylceramides and therefore
accumulate the inositolphosphorylceramide, IPC-C (Fig. 2, lane
2) (5, 19). Overaccumulation of IPC-C or a related metabolite
confers Ca21-sensitivity. Mutations in a variety of genes required for the synthesis of IPC-C suppress the Ca21-sensitive
phenotype of the csg2 mutants. For example, deletion of SCS7,
which encodes the enzyme that hydroxylates the VLCFA suppresses the Ca21 sensitivity of the csg2 mutant (Fig. 8) (6, 19).
Therefore, the effect of deletion of SUR2 on the Ca21 sensitivity
of the csg2D mutant was investigated. As shown in Fig. 8,
deletion of the SUR2 gene reverses the Ca21 sensitivity of a
csg2 mutant.
DISCUSSION

SUR2 Is Required for the Hydroxylation of C-4 of the LCB
and SCS7 Is Required for Hydroxylation of the VLCFA of Ceramides—The effect of deleting SUR2 on the hydroxylation of
C-4 on the LCB of ceramide and sphingolipid and the sequence
similarity between Sur2p and a family of desaturases/hydroxylases indicate that Sur2p catalyzes the hydroxylation of C-4.
The LCB of ceramides and sphingolipids in sur2D mutants is
dihydrosphingosine instead of the phytosphingosine predominantly found in wild-type cells. Exogenous phytosphingosine
restores synthesis of sphingolipids with a phytosphingosine
LCB in sur2D mutants.
The substrate (dihydrosphingosine or dihydroceramide) for
Sur2p has not been identified. Since hydroxylation of C-4 is not
required for ceramide or sphingolipid synthesis, either dihydrosphingosine or phytosphingosine can serve as substrate for
ceramide synthase, and either dihydroceramide or phytoceramide can serve as substrate for IPC synthase. S. cerevisiae cells
contain both dihydrosphingosine and phytosphingosine, and
inhibition of ceramide synthase by fumonisin B1 causes the
accumulation of both LCBs (29). However, it is not known
whether phytosphingosine comes from de novo synthesis or
from turnover of ceramide and sphingolipid.
Scs7p is also a member of this family of hydroxylases/desaturases, but it is responsible for hydroxylation of the VLCFA
rather than the LCB. Failure to hydroxylate C4 of the LCB
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FIG. 8. Suppression of the Ca21-sensitive phenotype of csg2D
mutants by deletion of SUR2 or SCS7. Cells were grown in synthetic medium to an OD600 of 0.1 and serially diluted (left to right, 1:5)
into the wells of a microtiter plate. Cells were transferred by metal
prong to SD agar plates without (2Ca) or with an additional 50 mM
CaCl2 (1Ca). The plates were incubated at 26 °C for three days.

decreases the Scs7p-catalyzed hydroxylation of the VLCFA,
indicating hydroxylation occurs subsequent to ceramide formation. Furthermore, the ceramides from SCS71 cells are hydroxylated, while those from scs7D mutant cells are not suggesting that the substrate for Scs7p is ceramide. However, it is
not yet known whether most of the free ceramides in the cell
arise from de novo synthesis or from turnover of sphingolipid,
so it remains to be determined whether the substrate for Scs7p
is free ceramide or inositolphosphorylceramide.
Martin and co-workers (16) recently reported that cells lacking the elongase encoded by ELO3/SUR4 accumulate relatively high levels of hydroxylated C16 fatty acids. We have
found that elo3 mutant cells incorporate fatty acids with
shorter than normal chain lengths into ceramide.2 Therefore, it
will be interesting to determine whether the hydroxylated C16
fatty acids in the mutants arise from Scs7p-catalyzed hydroxylation of the (shorter than normal) fatty acids on the ceramide.
Sur2p and Scs7p Are Members of a Family of Cytochrome
b5-dependent Enzymes Located in the Endoplasmic Reticulum—Ceramide and IPC-C are synthesized in the endoplasmic
reticulum (4) which appears to be the location of Scs7p and
Sur2p as well. Both Scs7p and Sur2p contain C-terminal sequences (KMKYE and VKKEK), matching a consensus sequence specifying retention in the endoplasmic reticulum (6,
30). In S. cerevisiae, all five proteins that are members of the
oxo-diiron family appear to reside in the endoplasmic reticulum. Along with Sur2p and Scs7p, these are d-9 fatty acid
desaturase (Ole1p), C-4 sterol methyl oxidase (Erg25p), and
C-5 sterol desaturase (Erg3p). The oxo-diiron centers in these
enzymes are believed to receive electrons from either cytochrome b5 or a cytochrome b5-like domain. Scs7p and Ole1p
contain cytochrome b5-like domains at their N and C termini
respectively (6, 31). Cytochrome b5 may function to transfer
electrons to Sur2p and the other two enzymes. Cytochrome b5
reductase may catalyze the reduction of both cytochrome b5
and the cytochrome b5-like domains on Scs7p and Ole1p.
Suppressors of the Ca21-sensitive Phenotype of csg2D Mutants, as Well as Suppressors of the Pleiotropic Phenotypes of
rvs161 Mutants, Identify Sphingolipid Synthesis Genes—The
Ca21 sensitivity of csg2 mutants is suppressed by deletion of
2
D. Haak, K. Gable, T. Beeler, and T. Dunn, unpublished
observations.

FIG. 7. Effect of arsenite and borate on the relative chromatographic mobilities of the C (lanes 1 and 2)-, B* (lane 3)-, B (lane
4)-, and A (lane 5)-ceramides. The isolated ceramides used in the
experiment described in Fig. 6 were analyzed by TLC on silica gel plates
without (panel A) or with either 1% sodium meta arsenite (panel B) or

1% sodium borate (panel C) as described by Karlsson and Pascher (27).
The borate plate and the untreated plate were run once in CHCl3:
CH3OH (95:5), while the arsenite plate was run twice in CHCl3:CH3OH:
AcOH (95:4.5:0.5).
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SUR2. Other mutations in sphingolipid biosynthetic genes
(subunits of serine palmitoyltransferase, LCB1, SCS1/LCB2;
ceramide hydroxylase, SCS7; fatty acid elongases, ELO2/
SUR5/FEN1, ELO3/SUR4; and fatty acid synthetase, FAS2)
also suppress the Ca21 sensitivity of csg mutants. These mutations either decrease the rate of sphingolipid synthesis or
alter the sphingolipids that are synthesized. The CSG2 and
CSG1 genes are required for mannosylation of IPC to form
MIPC. In the absence of mannosylation, IPC-C overaccumulation is observed. It appears that decreasing the accumulation of
IPC-C or a related metabolite or altering its structure (to
IPC-B, IPC-B9, or IPC-A?) reverses the Ca21 sensitivity. It is
hoped that continued analysis of suppressor mutants will identify more genes that function in sphingolipid synthesis and
identify the Ca21 target that triggers cell death.
The genetic relationship between suppressors of the csg2D
mutant and suppressors of the rvs161 mutant suggest a role for
sphingolipid in some Rvs161p-dependent process. Three genes
(SUR1, SUR2, and SUR4) (12) that mutate to suppress rvs161
mutants (10) are related to CSG1 and CSG2 or to genes that
mutate to suppress the Ca21-sensitive phenotype of csg1D and
csg2D mutants. The sur1, sur2, and sur4 mutants have altered
phospholipid compositions and abnormal morphologies in stationary phase (10). SUR1, which is allelic to CSG1 (5), is a high
copy suppressor of csg2D mutants (5, 32). Both SUR1/CSG1
and CSG2 are required for mannosylation of IPC (5, 19). SUR2
encodes the enzyme that hydroxylates C-4 of dihydroceramide.
SUR4/ELO3 and SUR5/ELO2/FEN1 encode fatty acid elongases required for the synthesis of the C26 fatty acids found in
ceramide and sphingolipids (16).
S. cerevisiae Cells Do Not Require Sur2p- or Scs7p-mediated
Hydroxylation for Growth or Synthesis of Mature Sphingolipid—The physiological function of Sur2p- and Scs7p-mediated
hydroxylation is not known. Growth of S. cerevisiae cells does
not depend on hydroxylation of either the C-4 of the LCB or the
VLCFA moieties of ceramides and sphingolipids. Cells lacking
serine palmitoyltransferase can utilize exogenous dihydrosphingosine or phytosphingosine but not sphingosine, the
main long chain base in mammals (25). Since sur2D mutants do
not synthesize phytosphingosine, it is not the lack of a C-4
hydroxyl group that precludes sphingosine from substituting
as the LCB in ceramide synthesis.
Deletion of SUR2 greatly increases the resistance of cells to
the Pseudomonas syringae cyclic lipodepsipeptide syringomycin (33) and to the morpholine fungicide fenpropimorph,2 an
inhibitor of several enzymes in the ergosterol synthesis pathway. As discussed above, deletion of SUR2 also suppresses the
Ca21-sensitive phenotype of csg2D mutants and the pleiotropic
effects of rvs161 mutations. Elucidation of the mechanism by

which blocking hydroxylation of the LCB C-4 increases the
ability of cells to tolerate syringomycin, fenpropimorph, and
high Ca21 concentrations after CSG2 deletion, and RVS161
deletion may provide clues as to how C-4 hydroxylation affects
the functional properties of the LCB, ceramide, and sphingolipids. In addition, the sur2D mutant can be used to identify
genetically related genes that encode proteins whose functional
properties are effected by C-4 hydroxylation.
Acknowledgments— We thank Ann Moser for the protocol for visualizing ceramides using 8-anilino-1-napthalene sulfonic acid, and Alan
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